Who holds viveve medical's stock?
Only 1.80% of the stock of Viveve Medical is held by insiders. Only 6.04% of the stock of Viveve Medical is held by institutions. Earnings for Viveve Medical are expected to grow in the coming year, from ($2.50) to ($1.84) per share.
How many shares of viveve medical are shorted?
Based on an average daily trading volume, of 436,800 shares, the days-to-cover ratio is currently 0.7 days. Currently, 3.0% of the company's shares are sold short. View Viveve Medical's Short Interest. When is Viveve Medical's next earnings date?
When is viveve medical's next quarterly earnings release?
Viveve Medical is scheduled to release its next quarterly earnings announcement on Thursday, February 10th 2022. View our earnings forecast for Viveve Medical. How were Viveve Medical's earnings last quarter?
When did viveve medical go public?
When did Viveve Medical IPO? (VIVE) raised $13 million in an initial public offering (IPO) on Tuesday, June 14th 2016. The company issued 1,600,000 shares at $8.00 per share. Ladenburg Thalmann and Craig-Hallum Capital Group acted as the underwriters for the IPO and Maxim Group was co-manager.
Why did viveve Medical stock drop?
(NASDAQ: VIVE) stock plunged to a 9-year low of $0.58 on Monday. Investors were concerned about the future of the medical technology company, which is focused on women's intimate health, after a weak fourth-quarter earnings results. Traders believed the company could fall into bankruptcy if the worries persisted.
Will viveve Medical stock go up?
Stock Price Forecast The 2 analysts offering 12-month price forecasts for Viveve Medical Inc have a median target of 5.75, with a high estimate of 6.25 and a low estimate of 5.25. The median estimate represents a +698.72% increase from the last price of 0.72.
Is viveve Medical a good stock to buy?
The consensus among 1 Wall Street analyst covering (NASDAQ: VIVE) stock is to Strong Buy VIVE stock.
About Viveve Medical
Viveve Medical (NASDAQ:VIVE) Frequently Asked Questions
Viveve Medical, Inc. engages in the design, development, manufacture, and marketing of platform medical technology. It offers cryogen-cooled monopolar radio frequency technology, which delivered through a radiofrequency generator, hand piece and treatment tip.
Referenced Symbols
Viveve Medical's stock was trading at $0.84 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, VIVE shares have decreased by 0.1% and is now trading at $0.8390. View which stocks have been most impacted by COVID-19.
More On MarketWatch
Shave of Viveve Medical Inc. VIVE, -0.15% sank 9.7% toward a record low in premarket trading Friday, after the provider of health products and women's health services filed for the sale of new common stock to the public.
About the Author
Barron's: PayPal Stock Had Its Worst Day on Record. What Wall Street Is Saying.
What Exactly Is Urinary Incontinence? And What to Do if You Experience Bladder Leaks
Tomi Kilgore is MarketWatch's deputy investing and corporate news editor and is based in New York. You can follow him on Twitter @TomiKilgore.
Depression
Do you cross your legs — and your fingers — every time you cough or sneeze hoping to avoid a leak? When going somewhere new, do you map routes to the nearest bathrooms along with your driving directions? Urinary incontinence, the accidental leaking of urine, can wreak...
The Skinny on Hormone Therapy
Nearly 7.1% of adults in the U.S. have experienced depression in their lifetime, with women being affected at twice the rate of men. In fact, depression is now the leading cause of disability worldwide. However, despite its prevalence, depression is still commonly...
Performance
- Viveve Medical Inc (NASDAQ:VIVE) posted its earnings results on Thursday, March, 14th. The company reported ($0.38) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.35) by $0.03. The firm earned $4.47 million during the quarter, compared to analyst estimates of $4.33 million. Viveve Medical had a negative net m...
Cost
- 4 equities research analysts have issued 1-year price targets for Viveve Medical's stock. Their forecasts range from $1.00 to $6.00. On average, they anticipate Viveve Medical's share price to reach $3.50 in the next twelve months. This suggests a possible upside of 614.3% from the stock's current price. View Analyst Price Targets for Viveve Medical.
Ratings
- 4 Wall Street analysts have issued \"buy,\" \"hold,\" and \"sell\" ratings for Viveve Medical in the last year. There are currently 1 hold rating and 3 buy ratings for the stock, resulting in a consensus recommendation of \"Buy.\" View Analyst Ratings for Viveve Medical. News articles about VIVE stock have trended neutral this week, according to InfoTrie Sentiment Analysis. InfoTrie rates th…
Funding
- (VIVE) raised $13 million in an initial public offering (IPO) on Tuesday, June 14th 2016. The company issued 1,600,000 shares at a price of $8.00 per share. Ladenburg Thalmann and Craig-Hallum Capital Group served as the underwriters for the IPO and Maxim Group was co-manager.
Ownership
- Viveve Medical's stock is owned by many different of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (1.60%), Pennsylvania Trust Co (0.09%), Pennsylvania Trust Co (0.09%), Raymond James Financial Services Advisors Inc. (0.08%) and Accredited Investors Inc. (0.07%). View Institutional Ownership Trends for Viveve Medical. VIVE …
Business
- Viveve Medical has a market capitalization of $22.78 million and generates $18.52 million in revenue each year. The company earns $-49,320,000.00 in net income (profit) each year or ($1.61) on an earnings per share basis. Viveve Medical employs 67 workers across the globe.
Location
- Viveve Medical's mailing address is 345 INVERNESS DRIVE SOUTH BUILDING B SUITE 250, ENGLEWOOD CO, 80112. The company can be reached via phone at 720-696-8100 or via email at [email protected].